Intuitive Surgical, Inc. $ISRG Stock: Carnegie Lake Advisors LLC Trims Holdings

Key Points

• Carnegie Lake Advisors cut its Intuitive Surgical position by 86.5% in the third quarter, selling 7,854 shares and retaining 1,221 shares valued at about $496,000.
• Institutional investors and hedge funds own 83.64% of the company, with several major investors increasing their stakes. Two directors also sold shares under pre-arranged Rule 10b5-1 plans.
• Intuitive Surgical beat quarterly earnings and revenue estimates, with revenue up 21.7% year over year; analysts’ consensus rating is “Moderate Buy,” with an average price target of $493.54.

Carnegie Lake Advisors LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 86.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,221 shares of the medical equipment provider's stock after selling 7,854 shares during the quarter. Intuitive Surgical accounts for about 0.4% of Carnegie Lake Advisors LLC's holdings, making the stock its 28th biggest position. Carnegie Lake Advisors LLC's holdings in Intuitive Surgical were worth $496,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Bank of America Corp DE increased its stake in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock valued at $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Intuitive Surgical during the second quarter worth $1,335,753,000. Amundi boosted its position in Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after purchasing an additional 193,096 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider's stock worth $769,948,000 after purchasing an additional 184,044 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Craig Barratt sold 1,150 shares of the company's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $510,370.00. Following the transaction, the director directly owned 1,150 shares in the company, valued at approximately $510,370. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the firm's stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the sale, the director directly owned 1,204,530 shares in the company, valued at $543,977,793.30. This represents a 1.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 49,128 shares of company stock worth $21,614,167 in the last ninety days. Company insiders own 0.60% of the company's stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Analyst Upgrades and Downgrades

Several analysts have weighed in on ISRG shares. KeyCorp reissued an "overweight" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Barclays reaffirmed an "overweight" rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. UBS Group reiterated a "buy" rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an "overweight" rating in a research note on Wednesday, October 21st. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $493.54.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $452.80 on Monday. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock's fifty day simple moving average is $409.93 and its 200-day simple moving average is $431.89. The company has a market capitalization of $156.96 billion, a P/E ratio of 54.75, a P/E/G ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts' consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter last year, the company earned $2.40 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Intuitive Surgical Profile

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.